Imunon, Inc. — Director's Dealing 2025

Mar 18, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Imunon, Inc. (IMNN)
CIK: 0000749647
Period of Report: 2025-03-14

Reporting Person: Eylward Susan (General Counsel and Corp Sec)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-03-14	Stock Option (Right to Buy)	$0.8651	A	6250	Acquired	2035-03-14	Common Stock (6250)	Direct

Footnotes

F1: Represents the closing price of Imunon, Inc. Common Stock on the date of the grant

F2: The options vest as follows: 1/2 on the date of grant; 1/4 on the one year anniversary of the date of grant; and 1/4 on the second year anniversary of the date of grant.